PATHWAY CAPITAL MANAGEMENT, LP
PATHWAY CAPITAL MANAGEMENT, LP latest Q4_2020 13F filings reported $1,280,000 in market value on this 2021-02-10 report date . The portfolio quarterly return is -98.86%. This fund has 2 securities concentrations of 100% weights.
PATHWAY CAPITAL MANAGEMENT, LP largest holding is Mersana Therapeutics Inc. with weight of 84.38% and $1,080,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.
Portfolio Performance History
|FILE DATE||REPORT PERIOD||QTR YEAR||FILE TYPE||NOS. OF STOCKS||REPORTED VALUE||RETURN|